COLEC12 and osteosarcoma: Furthermore, COLEC12 knockdown could increase inflammation of osteosarcoma, in vivo and in vitro, through inducing myeloperoxidase (MPO), TLR4, NF‐κB, and C3, and expression of related inflammatory factors.